Jump Trading’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-13,300
Closed -$1.27M 571
2018
Q2
$1.27M Sell
13,300
-16,100
-55% -$1.48M 0.1% 136
2018
Q1
$2.58M Buy
29,400
+24,200
+465% +$2.21M 0.24% 82
2017
Q4
$441K Sell
5,200
-5,200
-50% -$436K 0.06% 223
2017
Q3
$900K Sell
10,400
-13,000
-56% -$1.04M 0.16% 105
2017
Q2
$1.81M Buy
+23,400
New +$1.66M 0.27% 81
2016
Q3
Sell
-31,400
Closed -$1.7M 569
2016
Q2
$1.7M Buy
31,400
+31,345
+56,991% +$1.72M 0.08% 163
2016
Q1
$284K Buy
+55
New +$2.86K 0.01% 464
2015
Q3
Sell
-34,200
Closed -$2.88M 1001
2015
Q2
$2.88M Buy
+34,200
New +$2.66M 0.05% 123
2014
Q4
Sell
-900
Closed -$47K 1208
2014
Q3
$47K Sell
900
-2,400
-73% -$122K ﹤0.01% 899
2014
Q2
$169K Buy
+3,300
New +$149K 0.01% 564

Other funds holding XBI

Jump Trading's XBI Position: Q3 2018 in Review

Jump Trading sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2018, closing a stake of 8,954 shares — an estimated $852K sold.

Jump Trading first reported a position in XBI in Q1 2015 and held it in 4 quarters. The position peaked at $852K in Q2 2018. 432 funds tracked by Wall St. Rank hold XBI as of Q3 2018.

  • Jump Trading reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2018 after selling out during the quarter.
  • Jump Trading sold 8,954 State Street SPDR S&P Biotech ETF shares in Q3 2018, an estimated $852K.
  • Jump Trading first reported a position in State Street SPDR S&P Biotech ETF in Q1 2015 and held it in 4 quarters.
  • Jump Trading's State Street SPDR S&P Biotech ETF position peaked at $852K in Q2 2018.
  • 432 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2018.

Based on Jump Trading's 13F filing for Q3 2018, filed 14 Nov 2018.